BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31713780)

  • 1. Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma.
    Zheng H; Bi FR; Yang Y; Hong YG; Ni JS; Ma L; Liu MH; Hao LQ; Zhou WP; Song LH; Yan HL
    Horm Cancer; 2019 Dec; 10(4-6):177-189. PubMed ID: 31713780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA Circ-CCND1 Aggravates Hepatocellular Carcinoma Tumorigenesis by Regulating the miR-497-5p/HMGA2 Axis.
    Zheng S; Hou J; Chang Y; Zhao D; Yang H; Yang J
    Mol Biotechnol; 2022 Feb; 64(2):178-186. PubMed ID: 34564768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2.
    Xu X; Zou H; Luo L; Wang X; Wang G
    FEBS Open Bio; 2019 Oct; 9(10):1784-1797. PubMed ID: 31408273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
    J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1.
    Xu GS; Li ZW; Huang ZP; Brunicardi FC; Jia F; Song C; Zou HJ; Sun RF
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00860. PubMed ID: 31441605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
    Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
    Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
    Xu J; Wang Y; Zhang Y; Dang S; He S
    Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
    Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
    Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
    Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
    Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIAP 3'-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma.
    Wu WY; Tao SQ; Wang XN; Lobie PE; Wu ZS
    Tumour Biol; 2017 Jul; 39(7):1010428317719578. PubMed ID: 28691642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
    Huang W; Li J; Guo X; Zhao Y; Yuan X
    Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.